Alu methylation levels in case follow-up of type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20220324001

Enrollment

240

Registered

2022-03-24

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

240 patients whose blood pressure levels were monitored and were placed them into three groups: normal (74 samples), pre-DM (93 samples) and type 2 DM (73 samples). Type 2 DM

Interventions

DNA was extracted from the blood using proteinase K digestion and phenol-chloroform extraction protocols.

Experimental Genetic

Blood

Eligibility

Sex/Gender

All

Age

31 Years to 85 Years

Inclusion criteria

Inclusion criteria: Fasting blood sugar (FBS) levels were used to classify the 240 patients into three groups: 74 normal controls, 93 pre-DM patients, and 73 type 2 DM patients.

Exclusion criteria

Exclusion criteria: Cancer patients

Design outcomes

Primary

Measure	Time frame
Cancer at 12 months before the intervention Cancer Test	—

Secondary

Measure	Time frame
HIV at 12 months before the intervention HIV Test	—

Countries

Thailand

Contacts

Public ContactJirapan Thongsroy

Walailak University

ju_jirapan@hotmail.com0865513657

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026